Benzinga | Mar 30, 2021 06:02AM EDT

Fennec Pharmaceuticals Q4 EPS $(0.13) Up From $(0.18) YoY; Says Has ~$30M In Cash And No Outstanding Debt

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.13) per share. This is a 27.78 percent increase over losses of $(0.18) per share from the same period last year.